This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Pecsi Tudomanyegyetem. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Inventor Dávid Ernszt
Introduction
Dávid Ernszt is a notable inventor based in Komló, Hungary. He has made significant contributions to the field of biomedical research, particularly in the study of lymphoma. His work has implications for understanding and treating high-grade B-cell lymphoma in humans.
Latest Patents
Dávid Ernszt holds a patent for a mouse lymphoma cell line and an animal model of human high-grade B-cell lymphoma. The invention relates to a new, spontaneous mouse lymphoma cell line displaying CD19, B220, MHC II, surface IgG2a/kappa chain, and MAC-1, which is negative for CD5. This cell line serves as a basis for animal models of B-cell lymphoma and provides methods for assessing lymphoma propagation and expansion.
Career Highlights
Dávid Ernszt is affiliated with the University of Pécs, where he conducts his research and develops innovative solutions in the field of oncology. His work has garnered attention for its potential to advance the understanding of lymphoma and improve treatment options.
Collaborations
Dávid has collaborated with notable colleagues, including Péter Balogh and Tamás Kovács, to further his research endeavors. Their combined expertise enhances the impact of their work in the scientific community.
Conclusion
Dávid Ernszt's contributions to the field of lymphoma research exemplify the importance of innovation in medicine. His patent and ongoing research efforts are paving the way for advancements in understanding and treating this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile